{"name":"Alveus Therapeutics, Inc.","slug":"alveus-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ALV-100","genericName":"ALV-100","slug":"alv-100","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ALV-100","genericName":"ALV-100","slug":"alv-100","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-02-24","type":"pipeline","source":"globenewswire.com","summary":"Alveus Therapeutics Announces Second and Final Closing of - globenewswire.com","headline":"Alveus Therapeutics Announces Second and Final Closing of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPeTM4bmtQNGx4ZlB6QWFiaW12UlBnRFpQSlVqSUFFSk9VNGh1aGdUY3NvczBob3ZxT3lDeTI5cldSa0UxMjN5UENraU1iZm5IV0xiTHRnazJoWi1jdDFDaUU2aUcyWVNvMFdDVDVBd1N1Nmx2VVNzQW41WHl6YnBsbjhyelRuakJRdGVCWF83Q2FNV2VqNGI2aGRRVUR0V1J1My0zejRrdUllVGtZQVA3d20yZGhxa1dsV1B3cUk1d2FwMXRlSnhVZ0tILVV5WGhFS1R3RHV2cUxManhCWVpoWXJSdVZBSTZLbVFEYXJNVTVvejAyRjBBZ3lVcDBMa1o1bGp0cC1KNF9IaHZxaktSOEM4RTRJdw?oc=5","date":"2026-01-23","type":"regulatory","source":"globenewswire.com","summary":"Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity - globenewswire.com","headline":"Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNQS12cXQxZk1GYzRINXFCYUNrYWhsaGRxWkw0dm1sLVBmWUNlU0xnek9JeTR0NFk1TGhwRGVGVzFQUzNtRzdFcXdNeG16Wkd6cDFHbDJFeWNOVDZGNUp6RFdiSThiTjhUMW5wS2FCM2FJUlQyMGNQc1RNRmxNVVFJUFRRSGU3LWwzemtfS2hXQWN6RFZyTjZveVhn?oc=5","date":"2026-01-16","type":"pipeline","source":"Pharmaceutical Technology","summary":"InterAx and Alveus collaborate on small-molecule metabolic treatment - Pharmaceutical Technology","headline":"InterAx and Alveus collaborate on small-molecule metabolic treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxQR1RKOW90Q0pON092MTNxMjdudlVuc1BZTmJUX3FNQVZiWEpGRTBhNWdkQ3VsQnU1bThDdXJWNk5mM1p5NFNkanJKbTBWc2tmUTRBT0kzYjBwbzU3UnpjRmxGMVRuM2JLZ0F0bXBTeldWcVFhNjhxSmlxcXUzWU41MEVVMHA1Z1BNMnBQZUFINUgwSFlhLWl5SDVmT3d3ZHNIbVpfZmpOOVVvM2RvOTZobXBvaC1ORzQwOGdsTzVZYU9HX1B3cHFkbkNuU2xra1FBZUl0Z3Z1VllBcFY2NGkwM0stbjNTRGZKdWgwUnRmZGl3cmktMmc0MFJjNXNNMFJtNDVKcnVhWEE5R2hFTE9yNDZMN25ybFNxek4td0JtM1hyQTA?oc=5","date":"2026-01-15","type":"pipeline","source":"Business Wire","summary":"InterAx and Alveus Announce Strategic Research and Licensing Agreement to Develop Differentiated Therapeutic Candidate for Metabolic Disease - Business Wire","headline":"InterAx and Alveus Announce Strategic Research and Licensing Agreement to Develop Differentiated Therapeutic Candidate f","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNeGQ5RnJ0dG5KY05mZ1NUb25fMmNTc1E3X3ljOTN0U0xJVXJsbktjQzE0TGlXSjE0cFJ6Z1BNX2pCTXpzR0pQbThZcU9FNVBIRHhUYUNkUUtUTW5qbVRrWU81TkNGQVZJcENWWS1nOWhONlV0TUhsdmZMX0dlYThNNE5CMUF3UENzVHJORGE4MmxpMmFNU09wdFEtclBGUQ?oc=5","date":"2026-01-09","type":"pipeline","source":"Pharmaceutical Technology","summary":"Alveus debuts in obesity arena with $160m Series A - Pharmaceutical Technology","headline":"Alveus debuts in obesity arena with $160m Series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPSHhhWjlnRHVSa21rZTZMbXAtQXlYYjZQODBsOWpscTkxQmswc29hVEMwMEliTExxUjFFRkNvSmNwSmYzRlYyRE1KcWtrT2FRUl9DVzNjakF6TUhjR3N6bGVCQXBUMFZ5Sk1iRlMxRkY0ZVY4UkhVY29hOWVJQ2ZCeVVZN2tKdlZERE9tOGVzQVlZeTR5U1ZWbWVndWZNZ3JBOXl5Skc3T1NNQ09KbXVj?oc=5","date":"2026-01-08","type":"pipeline","source":"Fierce Biotech","summary":"Equipped with $160M series A, Alveus debuts into crowded obesity development landscape - Fierce Biotech","headline":"Equipped with $160M series A, Alveus debuts into crowded obesity development landscape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxOYkJ2T1RnYm9NVWJxd1EtZFhiV21hNGQ3TG9KWnlkYlhKX3BYSmlydnZ0aVV3Q2ljbHU5UW1GeGFFYXAwV0t2OE5tYXNZcHlabldDZnJvWmh1NUpoVUpmNG81N3lqdFNtbjRfdFBiU29uSlZoc2NZUE5MYW9udE5wTnRneTY4WkdYdFBDLThYclRXQ1ZNOUVRQXhFY3pvQzNaM1BFZDdzLXdLby1CWGRmYXphSHdzcmNvMjE5cnFiTzF3S3I4UGxmQWhZT2NoWWtDTWxHSlY5eFM4TU1tcWlsY0oyNFRnb1U3U1RQZ2NUczBaOWR4c19hUS1pNjFHY2dEamFCekJOQjBvRE1OV0NNZ2Z4c3dCcnFqdVZIUF9pV2FPd1B5cXp6a3FYdVFFcFpEblE?oc=5","date":"2026-01-08","type":"pipeline","source":"globenewswire.com","summary":"Alveus Therapeutics Launches with $160 Million Series A - globenewswire.com","headline":"Alveus Therapeutics Launches with $160 Million Series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOa1BmX0xjc0ZHaWlZREpJRmcwbkhfay1HV2ZCS3c5MURKMWduM2FXMTk3WENtQ1JsWjMyQ2NIaUhGYnZlaVlsT3RudXdpVzczdGt6cjNINVF2cGkzekFHRVF6WmZhT2tZQmE3Q1E3Yks1b3YtekxFTE04TEgxTS12MnR4ZTNwU3VYczlzNVlNa0Y5S3JzVTJUcGVLNHNzQjhx?oc=5","date":"2026-01-08","type":"pipeline","source":"BioPharma Dive","summary":"Alveus launches with $160M to advance MariTide-like obesity drug - BioPharma Dive","headline":"Alveus launches with $160M to advance MariTide-like obesity drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPeGhSa1RnckI3SWh2QkRMQ3dWX1hnQ1ROTGdxaTBIZUprem5UZlIzT3djdkoyanVlM0RHWEhVUXI2VUhPOFZvSXc2akQ3cnJXSjNFVjREZVpaUFdoaFFWbGU0Z0tfY1Zhemd3WHJJUjgzZE9CbnI4T2J0VDVpcWV3T2VNaU9id2lWcEpNd2Z3NHdyY28?oc=5","date":"2025-09-09","type":"pipeline","source":"East Carolina University","summary":"ECU Foundation welcomes new leadership and board members - East Carolina University","headline":"ECU Foundation welcomes new leadership and board members","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQa1E0OVNWX0dWQ0RXbnVTQy1vRnVxQ1pHcFZnVzVTOFpsOEplN2kxa014SFQ3YzNWalFpS0MyT1VkN2VxWnh1a2NRbkhnQi1lMHI4MjZFYjNwNFgycHZaYy1xcnJhSjRwREJkTnJzb3NuM29SRGc5VE1wbmxpal9PdEVuTFNXMVljT295MldtVkctUVNtMjVZNUN4S1ZJMlByZVQwUVlDNGpub29WcWJJMXdkUQ?oc=5","date":"2024-03-02","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Novo Nordisk Expands Boston Area Research and Early Development - Genetic Engineering and Biotechnology News","headline":"Novo Nordisk Expands Boston Area Research and Early Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxPZ3NSRUZYaHIyWmZvU2IxeEhpRU5Ed2hMdEVjemxZdk1lV18yZG1VZFNjb2ZVdEJ0WHZKSzdfUl9QWlpiOVhYSk1peXJZejUtbzItcVAweldjWF94OHdwWUh0enZuSk9rTXhuX05kOVZRbDJxSmF1Ui16SnZYSEZrck9vR251U0NmZzJwNEtrQk5fZlBQNm80SEJtMlM4cUg3dkVVb2Y2NGtIRzVzc3lMUXN2SnV0cDBWY21RbU5CQXRjbW1JRFY5Rk01QjN1VGVLUjh1S0Vaa3lZYWp5QlhzOG5kLVFvYS10RnNMS3hxNlN6OUFoY1lFZnFGTDFCVl83Tk9ac0ktSGtRdw?oc=5","date":"2023-10-03","type":"pipeline","source":"Business Wire","summary":"InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical Executive, Mark Levick, MD, Ph.D. as New Board Director - Business Wire","headline":"InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical Executive, Mark Levick, MD, Ph.D. as New Board Dire","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}